Bayer Pharma Ag v. Dr. Reddys Laboratories, Ltd

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Richard G. Andrews · 4,097 cases in index

Docket number

1:21-cv-00732

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

05/24/2021

1,113 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Bayer Pharma Ag · 88 cases
• defendant · Dr. Reddys Laboratories, Inc Pharmaceuticals & Biotechnology · 36 cases

Part of a Larger Litigation Pattern

This is one of 37 Patent - ANDA cases in our index naming DR. REDDYS LABORATORIES, INC — a possible mass-tort or coordinated-litigation cluster.

• Bayer HealthCare Pharmaceuticals Inc v. Dr. Reddys Laboratories, Ltd
  District Court, D. DelawareFiled 10/23/2025
• Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc
  District Court, D. DelawareFiled 07/29/2021
• Merck Sharp & Dohme Corp v. Dr. Reddys Laboratories, Inc
  District Court, D. DelawareFiled 07/15/2021
• AbbVie Inc v. Dr. Reddys Laboratories, Ltd
  District Court, D. DelawareFiled 07/21/2020
• Merck Sharp & Dohme B.V v. Dr. Reddys Laboratories, Inc
  District Court, D. New JerseyFiled 03/16/2020
• Bristol-Myers Squibb Company v. Dr. Reddys Laboratories, Ltd
  District Court, D. New JerseyFiled 10/03/2019

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Bayer Pharma Ag v. Dr. Reddys Laboratories, Ltd?

Bayer Pharma Ag v. Dr. Reddys Laboratories, Ltd is a federal patent - anda lawsuit filed on 05/24/2021 in the District Court, D. Delaware. The case is currently open in the federal court system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:21-cv-00732.

When was the case filed?

Bayer Pharma Ag v. Dr. Reddys Laboratories, Ltd was filed on 05/24/2021. The case is currently open.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.